364 related articles for article (PubMed ID: 34578420)
1. Type I Interferon Induction and Exhaustion during Viral Infection: Plasmacytoid Dendritic Cells and Emerging COVID-19 Findings.
Greene TT; Zuniga EI
Viruses; 2021 Sep; 13(9):. PubMed ID: 34578420
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 induces human plasmacytoid predendritic cell diversification via UNC93B and IRAK4.
Onodi F; Bonnet-Madin L; Meertens L; Karpf L; Poirot J; Zhang SY; Picard C; Puel A; Jouanguy E; Zhang Q; Le Goff J; Molina JM; Delaugerre C; Casanova JL; Amara A; Soumelis V
J Exp Med; 2021 Apr; 218(4):. PubMed ID: 33533916
[TBL] [Abstract][Full Text] [Related]
3. Sources of Type I Interferons in Infectious Immunity: Plasmacytoid Dendritic Cells Not Always in the Driver's Seat.
Ali S; Mann-Nüttel R; Schulze A; Richter L; Alferink J; Scheu S
Front Immunol; 2019; 10():778. PubMed ID: 31031767
[TBL] [Abstract][Full Text] [Related]
4. Ontogeny and Function of Plasmacytoid Dendritic Cells.
Adams NM; Das A; Yun TJ; Reizis B
Annu Rev Immunol; 2024 Jun; 42(1):347-373. PubMed ID: 38941603
[TBL] [Abstract][Full Text] [Related]
5. Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection.
Severa M; Diotti RA; Etna MP; Rizzo F; Fiore S; Ricci D; Iannetta M; Sinigaglia A; Lodi A; Mancini N; Criscuolo E; Clementi M; Andreoni M; Balducci S; Barzon L; Stefanelli P; Clementi N; Coccia EM
PLoS Pathog; 2021 Sep; 17(9):e1009878. PubMed ID: 34473805
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-27R Signaling Mediates Early Viral Containment and Impacts Innate and Adaptive Immunity after Chronic Lymphocytic Choriomeningitis Virus Infection.
Harker JA; Wong KA; Dallari S; Bao P; Dolgoter A; Jo Y; Wehrens EJ; Macal M; Zuniga EI
J Virol; 2018 Jun; 92(12):. PubMed ID: 29593047
[TBL] [Abstract][Full Text] [Related]
7. Sex Differences in Primary HIV Infection: Revisiting the Role of TLR7-Driven Type 1 IFN Production by Plasmacytoid Dendritic Cells in Women.
Guéry JC
Front Immunol; 2021; 12():729233. PubMed ID: 34512664
[TBL] [Abstract][Full Text] [Related]
8. Blimp-1-Mediated Pathway Promotes Type I IFN Production in Plasmacytoid Dendritic Cells by Targeting to Interleukin-1 Receptor-Associated Kinase M.
Ko YA; Chan YH; Liu CH; Liang JJ; Chuang TH; Hsueh YP; Lin YL; Lin KI
Front Immunol; 2018; 9():1828. PubMed ID: 30131810
[TBL] [Abstract][Full Text] [Related]
9. Viral infection switches non-plasmacytoid dendritic cells into high interferon producers.
Diebold SS; Montoya M; Unger H; Alexopoulou L; Roy P; Haswell LE; Al-Shamkhani A; Flavell R; Borrow P; Reis e Sousa C
Nature; 2003 Jul; 424(6946):324-8. PubMed ID: 12819664
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus pathogen associated molecular pattern (PAMP) triggers production of lambda-interferons by human plasmacytoid dendritic cells.
Stone AE; Giugliano S; Schnell G; Cheng L; Leahy KF; Golden-Mason L; Gale M; Rosen HR
PLoS Pathog; 2013; 9(4):e1003316. PubMed ID: 23637605
[TBL] [Abstract][Full Text] [Related]
11. IFN-γ production by human natural killer cells in response to HCV-infected hepatoma cells is dependent on accessory cells.
Zhang S; Saha B; Kodys K; Szabo G
J Hepatol; 2013 Sep; 59(3):442-9. PubMed ID: 23665181
[TBL] [Abstract][Full Text] [Related]
12. Mutation in
Das A; Chauhan KS; Kumar H; Tailor P
Front Immunol; 2021; 12():758190. PubMed ID: 34867997
[TBL] [Abstract][Full Text] [Related]
13. The Pseudorabies Virus Glycoprotein gE/gI Complex Suppresses Type I Interferon Production by Plasmacytoid Dendritic Cells.
Lamote JAS; Kestens M; Van Waesberghe C; Delva J; De Pelsmaeker S; Devriendt B; Favoreel HW
J Virol; 2017 Apr; 91(7):. PubMed ID: 28122975
[TBL] [Abstract][Full Text] [Related]
14. Type I Interferon Production of Plasmacytoid Dendritic Cells under Control.
Bencze D; Fekete T; Pázmándi K
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33919546
[TBL] [Abstract][Full Text] [Related]
15. Severe COVID-19 patients have impaired plasmacytoid dendritic cell-mediated control of SARS-CoV-2.
Venet M; Ribeiro MS; Décembre E; Bellomo A; Joshi G; Nuovo C; Villard M; Cluet D; Perret M; Pescamona R; Paidassi H; Walzer T; Allatif O; Belot A; Trouillet-Assant S; Ricci EP; Dreux M
Nat Commun; 2023 Feb; 14(1):694. PubMed ID: 36755036
[TBL] [Abstract][Full Text] [Related]
16. Plasmacytoid dendritic cells during COVID-19: Ally or adversary?
Van der Sluis RM; Holm CK; Jakobsen MR
Cell Rep; 2022 Jul; 40(4):111148. PubMed ID: 35858624
[TBL] [Abstract][Full Text] [Related]
17. Plasmacytoid dendritic cells produce type I interferon and reduce viral replication in airway epithelial cells after SARS-CoV-2 infection.
Cervantes-Barragan L; Vanderheiden A; Royer CJ; Davis-Gardner ME; Ralfs P; Chirkova T; Anderson LJ; Grakoui A; Suthar MS
bioRxiv; 2021 May; ():. PubMed ID: 34013278
[TBL] [Abstract][Full Text] [Related]
18. Macrophages and Dendritic Cells Are Not the Major Source of Pro-Inflammatory Cytokines Upon SARS-CoV-2 Infection.
Niles MA; Gogesch P; Kronhart S; Ortega Iannazzo S; Kochs G; Waibler Z; Anzaghe M
Front Immunol; 2021; 12():647824. PubMed ID: 34122407
[TBL] [Abstract][Full Text] [Related]
19. Human Plasmacytoid and Monocyte-Derived Dendritic Cells Display Distinct Metabolic Profile Upon RIG-I Activation.
Fekete T; Sütö MI; Bencze D; Mázló A; Szabo A; Biro T; Bacsi A; Pazmandi K
Front Immunol; 2018; 9():3070. PubMed ID: 30622542
[TBL] [Abstract][Full Text] [Related]
20. TLR2 and TLR7 mediate distinct immunopathological and antiviral plasmacytoid dendritic cell responses to SARS-CoV-2 infection.
van der Sluis RM; Cham LB; Gris-Oliver A; Gammelgaard KR; Pedersen JG; Idorn M; Ahmadov U; Hernandez SS; Cémalovic E; Godsk SH; Thyrsted J; Gunst JD; Nielsen SD; Jørgensen JJ; Bjerg TW; Laustsen A; Reinert LS; Olagnier D; Bak RO; Kjolby M; Holm CK; Tolstrup M; Paludan SR; Kristensen LS; Søgaard OS; Jakobsen MR
EMBO J; 2022 May; 41(10):e109622. PubMed ID: 35178710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
